Statistics for Nautilus Biotechnology, (id:8130 NAUT)
Valuation metrics
Market cap
301.35M
Enterprise value
189.80M
Trailing P/E (ttm)
-4.71
Forward P/E
-3.24
PEG ratio
-3.24
Price/Sales (ttm)
Price/Book (mrq)
1.35
Enterprise Value/Revenue
Enterprise Value/EBITDA
-2.39
Overview
Shares outstanding
125.56M
Float
41.95M
Shares short
1.21M
% Held by insiders
0.33%
% Held by institutions
0.50%
Average volume (10 days)
147.65K
Average volume (90 days)
Price summary
52-Week low
2.19
52-Week high
3.46
52-Week change
-19.58%
Beta
1.04
50-Day moving average
2.71
200-Day moving average
2.63
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-17.62%
Return on equity
-28.04%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-79,399,000.00
Net income to common (ttm)
-70,210,000.00
Diluted EPS (ttm)
-0.56
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
140.61M
Total cash per share (mrq)
1.12
Total debt (mrq)
31.57M
Total Debt/Equity (mrq)
14.13
Current ratio (mrq)
1.66K%
Book value per share (mrq)
1.78
Cash flow
Cash flow statement
-58,736,000.00
Levered free cash flow (LFCF)
-34,997,624.00